陈擎, 莫淋, 杨阳, 孟亚秋, 徐晓帆, 顾军. 乳腺导管原位癌的间质微浸润危险因素分析[J]. 中国肿瘤临床, 2016, 43(13): 567-570. DOI: 10.3969/j.issn.1000-8179.2016.13.478
引用本文: 陈擎, 莫淋, 杨阳, 孟亚秋, 徐晓帆, 顾军. 乳腺导管原位癌的间质微浸润危险因素分析[J]. 中国肿瘤临床, 2016, 43(13): 567-570. DOI: 10.3969/j.issn.1000-8179.2016.13.478
Qing CHEN, Lin MO, Yang YANG, Yaqiu MENG, Xiaofan XU, Jun GU. Risk factors of microinvasion in breast ductal carcinoma in situ[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 43(13): 567-570. DOI: 10.3969/j.issn.1000-8179.2016.13.478
Citation: Qing CHEN, Lin MO, Yang YANG, Yaqiu MENG, Xiaofan XU, Jun GU. Risk factors of microinvasion in breast ductal carcinoma in situ[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 43(13): 567-570. DOI: 10.3969/j.issn.1000-8179.2016.13.478

乳腺导管原位癌的间质微浸润危险因素分析

Risk factors of microinvasion in breast ductal carcinoma in situ

  • 摘要: 目的:分析乳腺导管原位癌(ductal carcinoma in situ,DCIS)间质微浸润的危险因素,探讨导管原位癌伴微浸润(ductal carcinoma in situ with microinvasion,DCIS-MI)患者的腋窝淋巴结术式。方法:回顾性分析2013年2 月至2016年2 月南京大学医学院附属金陵医院经手术后病理证实为DCIS、DCIS-MI 共45例患者临床资料,依据是否伴微浸润分为DCIS与DCIS-MI 组,对患者年龄、就诊时是否绝经、肿瘤大小等因素行统计学分析。结果:就诊时未绝经(P = 0.006)、肿物直径≥ 3.15cm(P = 0.006)、有恶性肿瘤家族史(P = 0.002)的患者更易发生肿瘤间质微浸润。结论:具有可触及腋窝肿物、未绝经、乳腺巨大肿物、有恶性肿瘤家族史危险因素,同时术前行穿刺或术中冰冻提示DCIS、DCIS伴可疑微浸润的患者存在微浸润可能性大,应予前哨淋巴结活检。触及腋窝肿物为首要症状患者,腋窝淋巴结清扫术应作为首选方式。

     

    Abstract: Objective:To analyze risk factors of breast ductal carcinoma in situ (DCIS) with microinvasion (DCIS-MI) and explore suitable axillary lymph node surgery treatment for patients with DCIS-MI. Methods:The clinical characteristics, such as age, menopausal status at diagnosis, size of breast mass, and pathology reports of 45patients with breast DCIS or DCIS-MI treated at Jinling Hospital, Medical School of Nanjing University from February 2013to February 2016, were retrospectively collected and analyzed statistically to deter -mine the risk factors associated with microinvasion.Results:Premenopause ( P=0. 006 ), tumor size ≥ 3. 15cm ( P=0. 006 ), and family his -tory of malignant tumor ( P=0. 002 ) were proven risk factors of DCIS-MI. Conclusion: Patients with clinical palpable axillary mass, pre  menopause, large breast mass, and family history of malignant tumor demonstrated high possibility of DCIS-MI. Hence, sentinel lymph node biopsy should be performed. Axillary lymph node dissection is highly recommended to patients whose main symptom is palpable axillary mass.

     

/

返回文章
返回